Systematic Reviews
Copyright ©The Author(s) 2021.
World J Gastroenterol. Apr 28, 2021; 27(16): 1828-1840
Published online Apr 28, 2021. doi: 10.3748/wjg.v27.i16.1828
Table 1 Synthetic presentation of data on fecal marker performance in detecting mucosal healing
Ref.
Study type
Investigated marker
MH definition
CU/CD
Number of patients
AUC
95%CI
Sn (%)
Sp (%)
Cutoff level
E Penna et al[22]Prospective cohortFCSES-CD ≤ 2CD65 + 21 individuals in the control group0.770.65-0.889678155 mcg/g
Hiraoka et al[17]Prospective cohortFCMES = 0UC840.670.56 - 0.787767180 mcg/g
Hiraoka et al[17]Prospective cohortFITMES = 0UC840.620.50- 0.749562NA
Lee et al[23]Prospective cohortFC-ELISA; FC-QPOCTMES = 0; SES-CD < 4UC + CD930.88NANA81.8(ELISA); 85.7 (QPOCT)100 ELISA; 100 QPOCT201 mcg/g ELISA; 150.5 mcg/g QPOCT
Urushikubo et al[24]Cross-sectional, observationalFCMES = 0; REI = 0; UCEIS = 0UC500.823; 0.780; 0.7770.707-0.939; 0.658-0.903; 0.645-0.909100; 100; 8862; 70; 71490 mcg/g; 288 mcg/g; 288 mcg/g
Ryu et al[18]Retrospective cohortFITMES = 0; UCEIS = 0-1UC128NANA98.0; 94.937.4; 38.3100 ng/mL
Ryu et al[18]Retrospective cohortFCMES = 0; UCEIS = 0-1UC128NANA78.4; 74.674.4; 76.5170 mcg/g
Lin et al[25]Multicentric prospective cohortFCUCEIS < 3; CDEIS < 6UC + CD880.87; 0.74NA88; 5075; 100191 mcg/g; 918 mcg/g
Vázquez Morón et al[26]Prospective cohortFCSES-CD ≤ 2CD71NANA95.952.371 mcg/g
Ryu et al[27]Retrospective cohortFITMES = 0-1UC630.810.59-0.9473.3381.82< 7 ng/mL
Hassan et al[28]Prospective cohortFCMES = 0-1UC440.9490.838-0.99289.793.358 mcg/g
Kostas et al[29] Retrospective cohortFCMES = 0-1; absence of mucosal lesions for CDUC + CD1490.956NA91.987.2174 mcg/g
Yen et al[21]Retrospective cohortFCMES = 0-1UC500.812NA74.1984.21156 mcg/g
Yen et al[21]Retrospective cohortiFOBTMES = 0-1UC500.906NA80.65100≤ 43 ng/mL
Kristensen et al[30]Prospective cohortFCMES = 0-1UC20NANA82.4100250 mcg/g